Nephrology · Clinical Calculator · Stones & Minerals

24-Hour Urine Calcium in Context

Read a 24-hour urinary calcium against the threshold that belongs to the clinical question: chronic hypoparathyroidism (ESE 2025), recurrent calcium stones (AUA 2026) or calcium phosphate stone prevention (EAU). The tool checks collection validity, converts units, shows sodium as a sodium chloride equivalent, trends repeat collections and tracks the urine output gap. It never suggests a dose.

Published: References: 5 Read time:

← All calculators & tools  ·  Calcium, urine calcium & kidney stones guide →

Instructions
  1. Screen for emergencies first. If the patient has symptomatic hypocalcemia, fever with a suspected obstructing stone, or anuria, tick the emergency box: all interpretation is suppressed.
  2. Choose the clinical context. Each context carries its own source and threshold; no threshold is applied outside its population.
  3. Describe the collection. Confirm that it was a complete 24-hour collection. Timed or incomplete collections are not extrapolated.
  4. Enter values with their units. Calcium as a concentration (mg/L or mmol/L, with volume) or a 24-hour total (mg or mmol). Sodium and creatinine are optional.
  5. Add the collection to the trend to compare baseline and follow-up collections side by side. Two collections that disagree stay visible; they are never averaged.

All computation runs in your browser. Values are kept only in this page's memory, are not saved, sent to analytics or placed in the address bar, and disappear when you press Reset or close the page.

When to Use

Use it when a 24-hour urinary calcium has to be interpreted for a specific decision: adjusting conventional therapy in chronic hypoparathyroidism (HypoPT), discussing thiazide therapy in a recurrent calcium stone former, or following hypercalciuria in calcium phosphate stone disease. Urinary calcium is a continuous risk marker; the flags show where a guideline draws a line for that population, not a diagnosis.

⚠️

When NOT to rely on it

Pregnancy, age under 18, dialysis, kidney transplant and advanced chronic kidney disease (CKD) receive no generalized interpretation, because the cutoffs were defined in routine adults. Do not interpret a collection made during an acute stone episode, with infection, after a recent change in diet or medicines, or within about 20 days of an intervention.

Pearls & Pitfalls
💡

Check the creatinine before the calcium

An incomplete collection lowers every analyte. Commonly used expected 24-hour creatinine excretion is roughly 15–20 mg/kg in men and 10–15 mg/kg in women (approximate; muscle mass and age move it). The tool warns when creatinine falls far outside these ranges.

🧂

Read calcium beside sodium

At steady state, urinary sodium approximates intake. High sodium raises calciuria and blunts thiazides; the sodium chloride figure is a chemical equivalent (sodium mmol × 0.05844 g), not a measured salt intake.

🚫

Never answer high urine calcium with more calcium

In treated HypoPT, hypercalciuria calls for a joint review of calcium and active vitamin D doses, sodium and possibly a thiazide. This tool shows no dose or titration output by design.

Urinary calcium, sodium and collection validity

The threshold, source and wording change with the context.
Unknown suppresses sex-specific thresholds.
Needed for mg/kg/24 h and the creatinine check.
Only 24-hour collections are interpreted.

Enter the collection details to see results.

⚕ Calcium 40.078 mg/mmol; sodium 22.98977 mg/mmol; sodium chloride equivalent (g) = sodium (mmol) × 0.05844. Comparisons use exact values before display rounding. Rules are versioned (last reviewed 21 Nov 2026) and tied to their sources below. Educational aid for clinicians; no dose recommendations.

Urine output and collection log

Unknown or restricted suppresses the default reference.
Leave blank to use the 2.5 L/day reference only when eligible.

Enter a measured output.

⚕ Gap = max(goal − measured output, 0), labeled as urine output. The tool does not convert fluid intake to urine output. A 2026 randomized trial (PUSH) found that an adherence program raised urine volume without reducing symptomatic stone events, so this log tracks output and makes no recurrence claim.

Next Steps
  • Above the ESE hypoparathyroidism threshold: review calcium and active vitamin D doses together, reduce sodium, consider a thiazide with monitoring of blood pressure, potassium, magnesium and creatinine, recheck within 1–2 weeks, and consider endocrine referral for parathyroid hormone (PTH) replacement if hypercalciuria persists.
  • At or above the AUA example in a recurrent calcium stone former: confirm with a repeat collection after diet and sodium changes; a thiazide or thiazide-like diuretic is then a shared decision (AUA Statement 18: moderate recommendation, evidence grade C), weighing NOSTONE's uncertain event benefit and metabolic harms.
  • Above 8 mmol/24 h with calcium phosphate stones: the EAU recommends a thiazide (strong); follow urine pH and supersaturation if alkali is also used.
  • Collections disagree: look for collection error, diet change or intercurrent illness before acting; repeat if needed.
  • Use the companion tools for the rest of the panel: the 24-hour urine stone risk profile, the elemental calcium ledger and the urine anion gap.
Evidence & Rules

Rule register (versioned)

Rule IDPopulationOperator and thresholdSourceReviewed
HP-CALCIURIAAdult chronic HypoPT> 250 mg/24 h women; > 300 mg/24 h men; > 4 mg/kg/24 h (canonical mg; mmol equivalents 6.25, 7.5 and 0.1/kg shown as approximations); equal = boundaryESE 2025, R.3.5.22026-11-21
AUA-CALCIURIAAdult confirmed recurrent calcium stones≥ 200 mg/24 h women; ≥ 250 mg/24 h men (examples of increased risk)AUA 2026, discussion of Statement 182026-11-21
EAU-CAPCalcium phosphate stone prevention> 8 mmol/24 h (native unit)EAU Urolithiasis Guidelines, metabolic evaluation2026-11-21
OUTPUTEligible adults without fluid restrictionReference 2.5 L/day urine outputEAU (> 2.5 L/day urine volume, strong); AUA 2026 (about 2.5 L/day water intake)2026-11-21

Verified fixtures

  • 160 mg/L × 2.0 L (complete) = 320 mg/24 h ≈ 7.98 mmol/24 h; 4.57 mg/kg/24 h at 70 kg; EAU > 8 is false.
  • 8.00 mmol/24 h → EAU false; 8.01 → true. 250 mg/24 h, female HypoPT → boundary; female AUA context → meets the example.
  • Sodium 100 mmol/24 h ≈ 2,299 mg sodium ≈ 5.84 g sodium chloride equivalent.
  • Output 1.6 L against a 2.5 L goal → 0.9 L urine output gap.
Important: This calculator is an educational aid for licensed clinicians. It applies each threshold only in its source population, suppresses interpretation in excluded groups and emergencies, and gives no dosing advice. Confirm collection validity and clinical context before acting.
References 5 sources
  1. Bollerslev, J., Buch, O., Cardoso, L. M., Gittoes, N., Houillier, P., van Hulsteijn, L., Makay, O., Marcocci, C., Pallais, J. C., Pilz, S., Rejnmark, L., Yavropoulou, M., & Dekkers, O. M. (2025). Revised European Society of Endocrinology clinical practice guideline: Treatment of chronic hypoparathyroidism in adults. European Journal of Endocrinology, 193(5), G83–G112. https://doi.org/10.1093/ejendo/lvaf222
  2. Pearle, M. S., Matlaga, B. R., Antonelli, J. A., Asher, G. N., Chi, T., Hsi, R. S., Kim, S. K., Kirkby, E., Knudsen, B., Koo, K., Maalouf, N. M., Pais, V. M., Paris, A., Penniston, K. L., Scotland, K. B., Streeper, N., Tasian, G., Wood, K. D., & Ziemba, J. B. (2026b). Medical management of kidney stones: AUA guideline (2026) Part II: Treatment and follow-up of kidney stones. Journal of Urology, 216(5), 623–631. https://doi.org/10.1097/JU.0000000000005228
  3. Desai, A. C., Maalouf, N. M., Harper, J. D., Sivalingam, S., Lieske, J. C., Lai, H. H., Reese, P. P., Wessells, H., Yang, H., Al-Khalidi, H. R., Kirkali, Z., Tasian, G. E., Scales, C. D., & Urinary Stone Disease Network Investigators. (2026). Prevention of urinary stones with hydration: A randomised clinical trial of an adherence intervention. Lancet, 407(10534), 1171–1181. https://doi.org/10.1016/S0140-6736(25)02637-6
  4. Dhayat, N. A., Bonny, O., Roth, B., Christe, A., Ritter, A., Mohebbi, N., Faller, N., Pellegrini, L., Bedino, G., Venzin, R. M., Grosse, P., Hüsler, C., Koneth, I., Bucher, C., Del Giorno, R., Gabutti, L., Mayr, M., Odermatt, U., Buchkremer, F., . . . Fuster, D. G. (2023). Hydrochlorothiazide and prevention of kidney-stone recurrence. New England Journal of Medicine, 388(9), 781–791. https://doi.org/10.1056/NEJMoa2209275
  5. Skolarikos, A., Somani, B., Neisius, A., Jung, H., Petřík, A., Tailly, T., Davis, N., Tzelves, L., Geraghty, R., Lombardo, R., Bezuidenhout, C., & Gambaro, G. (2024). Metabolic evaluation and recurrence prevention for urinary stone patients: An EAU guidelines update. European Urology, 86(4), 343–363. https://doi.org/10.1016/j.eururo.2024.05.029
Dr. W Rivero, MD

W Rivero, MD, FPCP, DPSN

Specialist in Internal Medicine, Nephrology, and Clinical Nutrition. Practicing integrative and evidence-based nephrology across Quezon City, Pampanga, and Bulacan.

· Book an Appointment →

QR code — scan to save Dr. Rivero's contact info

Scan and save

All Calculators Related Guides